Evaluation of Patients with Hyperuricemia - Flowchart
Evaluation of Patients with Hyperuricemia - Flowchart Hyperuricemia Hyperuricemia
«Flowchart»

Start

Start

Start

Consider secondary causes of hyperuricemia associated with elevated uric acid production

Consider secondary causes of hyperuricemia associated with elevated uric acid production

Consider secondary causes of hyperuricemia associated with elevated uric acid production

Treat

Treat

Treat

Routine medical management

Routine medical management

Routine medical management

Correct underlying cause if possible and/or appropriate

Correct underlying cause if possible and/or appropriate

Correct underlying cause if possible and/or appropriate

Hyperuricemic symptoms

Hyperuricemic symptoms

Hyperuricemic

Asymptomatic

Asymptomatic

Asymptomatic

End

End

End


Myeloproliferative diseases
Lymphoproliferative diseases
Hemolytic anemias
Polycythemia vera
Solid tumor malignancies
Psoriasis
Glycogen storage disease
Obesity
Ethanol
Fructose (large dose)
Tissue necrosis
Exercise
Convulsions
Drugs


Cytotoxic agents
B12 (patients with pernicious anemia)
Pancreatic extract


Myeloproliferative diseases
Lymphoproliferative diseases
Hemolytic anemias
Polycythemia vera
Solid tumor malignancies
Psoriasis
Glycogen storage disease
Obesity
Ethanol
Fructose (large dose)
Tissue necrosis
Exercise
Convulsions
Drugs


Cytotoxic agents
B12 (patients with pernicious anemia)
Pancreatic extract


Myeloproliferative diseases
Lymphoproliferative diseases
Hemolytic anemias
Polycythemia vera
Solid tumor malignancies
Psoriasis
Glycogen storage disease
Obesity
Ethanol
Fructose (large dose)
Tissue necrosis
Exercise
Convulsions
Drugs


Cytotoxic agents
B12 (patients with pernicious anemia)
Pancreatic extract


Myeloproliferative diseases
Lymphoproliferative diseases
Hemolytic anemias
Polycythemia vera
Solid tumor malignancies
Psoriasis
Glycogen storage disease
Obesity
Ethanol
Fructose (large dose)
Tissue necrosis
Exercise
Convulsions
Drugs


Cytotoxic agents
B12 (patients with pernicious anemia)
Pancreatic extract


Cytotoxic agents
B12 (patients with pernicious anemia) 12
Pancreatic extract

Treat

Treat

Treat

Treat

Treat

Treat

Close follow-up of renal function

Close follow-up of renal function

Close follow-up of renal function

Routine medical management

Routine medical management

Routine medical management

Treat

Treat

Treat

Symptomatic

Symptomatic

Symptomatic

Asymptomatic

Asymptomatic

Asymptomatic

Routine medical management

Routine medical management

Routine medical management

Follow renal function closely

Follow renal function closely

Follow renal function closely

Routine medical management

Routine medical management

Routine medical management

Consider acquired causes of hyperuricemia associated with normal urinary acid excretion

Consider acquired causes of hyperuricemia associated with normal urinary acid excretion

Consider acquired causes of hyperuricemia associated

Cause of hyperuricemia is not discernible

Cause of hyperuricemia is not discernible

Cause of hyperuricemia is not discernible

If positive and patient is asymptomatic and not in clinical setting for acute uric acid nephropathy

If positive and patient is asymptomatic and not in clinical setting for acute uric acid nephropathy

If positive

If positive and clinical setting for acute uric acid nephropathy: Myelo- or lymphoproliferative disorder, solid tumor with anticipated cytotoxic and/or radiation therapy, inherited disorders with overproduction of uric acid, or rhabdomyolysis

If positive and clinical setting for acute uric acid nephropathy: Myelo- or lymphoproliferative disorder, solid tumor with anticipated cytotoxic and/or radiation therapy, inherited disorders with overproduction of uric acid, or rhabdomyolysis

If positive and clinical

If positive and hyperuricemic symptoms

If positive and hyperuricemic symptoms

If positive and hyperuricemic


Obesity
Ethanol
Drugs


Salicylates (low dose)
Diuretics
Pyrazinamide
Ethambutol
Nicotinic acid
Laxative abuse (alkalosis)


Cyclosporine
Renal insufficiency
Polycystic kidney disease
Lead nephropathy
Hypothyroidism
Hyperparathyroidism
Diabetic ketoacidosis
Lactic acidosis
Starvation
Dehydration
Salt restriction
Diabetes insipidus
Bartter syndrome
Sarcoidosis
Down syndrome
Toxemia of pregnancy
Hypoxemia
Chronic beryllium disease


Obesity
Ethanol
Drugs


Salicylates (low dose)
Diuretics
Pyrazinamide
Ethambutol
Nicotinic acid
Laxative abuse (alkalosis)


Cyclosporine
Renal insufficiency
Polycystic kidney disease
Lead nephropathy
Hypothyroidism
Hyperparathyroidism
Diabetic ketoacidosis
Lactic acidosis
Starvation
Dehydration
Salt restriction
Diabetes insipidus
Bartter syndrome
Sarcoidosis
Down syndrome
Toxemia of pregnancy
Hypoxemia
Chronic beryllium disease


Obesity
Ethanol
Drugs


Salicylates (low dose)
Diuretics
Pyrazinamide
Ethambutol
Nicotinic acid
Laxative abuse (alkalosis)


Cyclosporine
Renal insufficiency
Polycystic kidney disease
Lead nephropathy
Hypothyroidism
Hyperparathyroidism
Diabetic ketoacidosis
Lactic acidosis
Starvation
Dehydration
Salt restriction
Diabetes insipidus
Bartter syndrome
Sarcoidosis
Down syndrome
Toxemia of pregnancy
Hypoxemia
Chronic beryllium disease


Obesity
Ethanol
Drugs


Salicylates (low dose)
Diuretics
Pyrazinamide
Ethambutol
Nicotinic acid
Laxative abuse (alkalosis)


Salicylates (low dose)
Diuretics
Pyrazinamide
Ethambutol
Nicotinic acid
Laxative abuse (alkalosis)
Cyclosporine
Renal insufficiency
Polycystic kidney disease
Lead nephropathy
Hypothyroidism
Hyperparathyroidism
Diabetic ketoacidosis
Lactic acidosis
Starvation
Dehydration
Salt restriction
Diabetes insipidus
Bartter syndrome
Sarcoidosis
Down syndrome
Toxemia of pregnancy
Hypoxemia
Chronic beryllium disease

Positive

Positive

Positive

Negative

Negative

Negative

24-hour urine uric acid

24-hour urine uric acid

24-hour urine uric acid

>1100 mg/day

>1100 mg/day

>1100 mg/day

<1100 mg/day

<1100 mg/day

<1100 mg/day

24-hour urine uric acid

24-hour urine uric acid

24-hour urine uric acid

>1100 mg/day

>1100 mg/day

>1100 mg/day

<1100 mg/day

<1100 mg/day

<1100 mg/day

Serum urate >11 mg/dl

Serum urate >11 mg/dl

Serum urate >11

Serum urate <11 mg/dl

Serum urate <11 mg/dl

Serum urate <11